Washington University
St Louis, United States
David H. Gutmann received his undergraduate, graduate (PhD) and medical (MD) degrees from the University of Michigan, followed by residency training in Neurology at the University of Pennsylvania. He then returned to the University of Michigan for research fellowship training in Human Genetics with Dr. Francis Collins, where he identified the neurofibromatosis type 1 (NF1) protein and its function as a RAS regulator. Dr. Gutmann is currently the Donald O. Schnuck Family Professor and Director of the Washington University Neurofibromatosis Center. His laboratory is focused on understanding the genomic, molecular and cellular basis for nervous system problems affecting people with NF1 using human induced pluripotent stem cells and novel genetically engineered mouse strains. The use of NF1 as an experimental model system has revealed numerous insights into the basic neurobiology of human disease relevant to cancer immunology, cancer neuroscience, and developmental biology. Dr. Gutmann has published over 490 peer-reviewed manuscripts, and his research laboratory has been continuous funded by the National Institutes of Health since 1993. In addition, he has been recognized for his achievements with numerous awards, including the 2012 Children’s Tumor Foundation Frederich von Recklinghausen Lifetime Achievement Award, the 2013 Washington University Distinguished Faculty Research Award, a National Institute of Neurological Disorders and Stroke R35 Research Program (MERIT) Award, the 2017 Alexander von Humboldt Award, the 2019 Society for Neuro-Oncology Abhijit Guha Award, the 2020 National Neurofibromatosis Network Advocate of Hope Award, the 2020 American Academy of Neurology Neuro-Oncology Scientific Award, and the 2020 American Association of Neurology triennial George W. Jacoby Award. He is a Fellow of the American Academy of Neurology, the American Neurological Association, the Association of American Physicians, and the American Association for the Advancement of Science, as well as a former member of the National Institute of Neurological Disorders and Stroke Advisory Council.